Fundraising FoxMymamedical
1 known investors
Find your way into Mymamedical
Sign up to see every warm intro you have to Mymamedical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mymamedical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Myma Medical develops autoICSI, an automation system for the ICSI (intracytoplasmic sperm injection) procedure used in IVF clinics, applying AI for gamete selection and automating gamete pickup and micro-manipulation. The technology aims to reduce embryologists' time-consuming tasks and improve workflow in assisted reproduction.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- MYMA MEDICAL LIMITED
- Company number
- 12983130
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 29 Oct 2020
- Registered office
- C/O Stuart Mcbain Ltd (Accountants), 7 De Havilland Drive, Liverpool, L24 8RN
- Nature of business (SIC)
- 74909 — Other professional, scientific and technical activities n.e.c.
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 23 Nov 2025 · next due 7 Dec 2026
Current officers · 4
- Amir Mohammad Hajiyavand — director, appointed 1 Jul 2021
- Yashvin Amarshi Khandhia — director, appointed 29 Oct 2020
- Robert Crowther Milnes — director, appointed 23 Dec 2022
- Mozafar Saadat — director, appointed 29 Oct 2020
Source: Companies House public register · retrieved 30 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Mymamedical do?
- Myma Medical develops autoICSI, an automation system for the ICSI (intracytoplasmic sperm injection) procedure used in IVF clinics, applying AI for gamete selection and automating gamete pickup and micro-manipulation. The technology aims to reduce embryologists' time-consuming tasks and improve workflow in assisted reproduction.
- Who are Mymamedical's investors?
- Mymamedical's investors include Deepbridge Capital.